1426699-91-3Relevant academic research and scientific papers
HETEROCYCLYLAMINES AS PI3K INHIBITORS
-
Paragraph 1042, (2013/03/26)
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
